Diabetes patients on insulin, suffering from acute injection phobia, have an alternative with the launch of Oral-Recosulin , a recombinant DNA human insulin buccal spray. The spray, which is on phase-3 trial and yet to be launched in the US, has been approved for marketing in India. Join discussion...